Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

NIH 6NETWORK 2OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia 22Burkitt Lymphoma 17Central Nervous System Neoplasms 15Neuroblastoma 13Lymphoma, Large B-Cell, Diffuse 13Sarcoma 11Lymphoma, Follicular 11Hodgkin Disease 10Brain Neoplasms 10Medulloblastoma 9Rhabdomyosarcoma 8Wilms Tumor 7Leukemia, Biphenotypic, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large-Cell, Anaplastic 6Oligodendroglioma 5Lymphoma, Mantle-Cell 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Multiple Myeloma 4Malignant mesenchymal tumor 4Dendritic Cell Sarcoma, Interdigitating 4Astrocytoma 4Waldenstrom Macroglobulinemia 3Sarcoma, Ewing 3Rhabdoid Tumor 3Lymphoma, Large-Cell, Immunoblastic 3Ganglioneuroblastoma 3

Interventions

Melphalan 5Dexamethasone 5Prednisone 4Peripheral Blood Stem Cell Transplantation 3Doxorubicin 3Vincristine 2Thalidomide 2Lenalidomide 2Filgrastim 2Cyclophosphamide 2valspodar 1sargramostim 1fludarabine phosphate 1Vancomycin 1Tazobactam 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Platelet Aggregation 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Moxifloxacin 1Morphine 1Methotrexate 1Interferon-alpha 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Gene Expression Profiling 1Fenretinide 1Etoposide 1Dextromethorphan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Neoplasms, Plasma Cell × Vincristine × Clear all
NCT00002878 2023-06-15

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Eastern Cooperative Oncology Group

Phase 3 Completed
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00002657 2013-01-24

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

SWOG Cancer Research Network

Phase 2 Completed
20 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡